Lichenoid eruption associated with the use of nebivolol

Annals of Pharmacotherapy

Volumn 40, Issue 9, 2006, Pages 1688-1691

  Bodmer, Michael ^a   Egger, Sabin S ^a   Hohenstein, Elisabeth ^a   Beltraminelli, Helmut ^a   Krähenbühl, Stephan ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Lichenoid drug eruption; Nebivolol

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LEVOCETIRIZINE; METHYLPREDNISOLONE; NEBIVOLOL; PREDNISONE;

ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CASE REPORT; CELL INVASION; CROSS REACTION; DRUG WITHDRAWAL; FEMALE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; LICHEN PLANUS; LICHENOID ERUPTION; PRIORITY JOURNAL; PROBABILITY; RASH; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION;

BENZOPYRANS; ETHANOLAMINES; FEMALE; HUMANS; LICHENOID ERUPTIONS;

EID: 33748291575     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H094     Document Type: Article

References (25)

1. Armour K, Lowe P. Complicated lichenoid drug eruption. Australas J Dermatol 2005;46:21-4.
2. Thompson DF, Skaehill PA. Drug-induced lichen planus. Pharmacotherapy 1994;14:561-71.
3. Ellgehausen P, Elsner P, Burg G. Drug-induced lichen planus. Clin Dermatol 1998;16:325-32.
4. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
5. Fedele R, Ricciardi L, Mazzeo L, Isola S. Allergic contact dermatitis to nebivolol. Allergy 2002;57:864-5.
6. Richards S. Cutaneous side-effects of beta-adrenergic blockers. Australas J Dermatol 1985;26:25-8.
7. Edwards PC, Kelsch R. Oral lichen planus: clinical presentation and management. J Can Dent Assoc 2002;68:494-9.
8. Nicholls JT. Adverse effects of practolol. Ann Clin Res 1976;8:229-31.
9. Massa MC, Jason SM, Gradini R, Welykyj S. Lichenoid drug eruption secondary to propranolol. Cutis 1991;48:41-3.
10. Kauppinen K, Niemi KM, Salo OP. Cutaneous reactions to practolol. Clinical and histopathological study. Ann Clin Res 1976;8:232-40.
11. Hawk JL. Lichenoid drug eruption induced by propanolol. Clin Exp Dermatol 1980;5:93-6.
12. Meyer S, Burgdorff T, Szeimies RM, Vogt T, Landthaler M, Karrer S. Management of erosive lichen planus with topical tacrolimus and recurrence secondary to metoprolol. J Eur Acad Dermatol Venereol 2005; 19:236-9.
13. Neumann HA, Van Joost T, Westerhof W. Dermatitis as side-effect of long-term metoprolol (letter). Lancet 1979;2:745.
14. Gange RW, Levene GM. A distinctive eruption in patients receiving oxprenolol. Clin Exp Dermatol 1979;4:87-97.
15. Palatsi R. A skin reaction to pindololum, a beta-blocking drug. Ann Clin Res 1976;8:239-40.
16. O'Brien TJ, Lyall IG, Reid SS. Lichenoid eruption induced by sotalol. Australas J Dermatol 1994;35:93-4.
17. Gange RW, Jones EW. Bullous lichen planus caused by labetalol. Br Med J 1978;1:816-7.
18. Bertani E, Sala F, Crosti C, Terragni L. Lichenoid cutaneous eruptions caused by labetalol. G Ital Dermatol Venereol 1982;117:229-32.
19. Taylor AE, Hindson C, Wacks H. A drug eruption due to acebutolol with combined lichenoid and lupus erythematosus features. Clin Exp Dermatol 1982;7:219-21.
20. Mullins RJ, Lones R, Dutta B. Lichenoid drug eruption secondary to topical timolol and dorzolamide eye-drops. Australas J Dermatol 2004;45: 151-2.
21. Beckman KA, Chanes L, Kaufman SR. Lichen planus associated with topical beta-blocker therapy. Am J Ophthalmol 1995;120:530-1.
22. Cribier B, Frances C, Chosidow O. Treatment of lichen planus. An evidence-based medicine analysis of efficacy. Arch Dermatol 1998;134: 1521-30.
23. Flier J, Boorsma DM, van Beek PJ, et al. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 2001;194:398-405.
24. Shiohara T, Mizukawa Y. The immunological basis of lichenoid tissue reaction. Autoimmun Rev 2005;4:236-41.
25. Sato M, Tokuda N, Fukumoto T, Mano T, Sato T, Ueyama Y. Immunohistopathological study of the oral lichenoid lesions of chronic GVHD. J Oral Pathol Med 2006;35:33-6.